官方服务：
资源简介：
iTRAQ analysis of paroxetine responsive MDD patients and western blot validations
应用场景：
创建时间：
2022-03-01
相关数据集
Evaluation of volumetric absorptive microsampling and mass spectrometry data-independent acquisition in hemoglobin related clinical markers
Data-independent acquisition (DIA) allows comprehensive proteome coverage, and it has the potential to work as a unified protocol to determine a multitude of proteins in blood. Because of its high spe
NIAID Data Ecosystem50
Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study
Treatment options for autosomal dominant polycystic kidney disease (ADPKD) will likely become available in the near future, hence reliable diagnostic and prognostic biomarkers for the disease are stro
Figshare2016-01-19 更新10
Proteins with nominal evidence for change (unadjusted p<0.05) during treatment of the protein array cohort (n=22 patients).
Proteins with nominal evidence for change (unadjusted p
Figshare2018-12-28 更新00
Data for: Proteomics of the acid-soluble fraction of whole and major gland saliva in burning mouth syndrome patients.
Fig. s1: XIC peak areas (mean ± SD) of salivary cystatins (a), histatins (b), bPRPs (c) analysed in the acid-soluble fraction of resting whole saliva (1), stimulated whole saliva (2), parotid saliva
NIAID Data Ecosystem30
Control Of Major Bleeding After Trauma (COMBAT) Clinical Research Trial
Denver Health has conducted the Control of Major Bleeding After Trauma (COMBAT) clinical research study, which aimed to improve trauma care for all patients (https://www.denverhealth.org/services/trau
NIAID Data Ecosystem10
